Skip to main content
Accessibility
Contrast
Text size

Lessons for industrial policy from development of the Oxford/AstraZeneca Covid-19 vaccine

The success of the UK’s Covid-19 vaccine procurement programme provides lessons for future industrial policy in the UK.

In this paper the Industrial Strategy Council explores how the Government’s mission to secure Covid-19 vaccines at speed played a key role in expediting development of new vaccines in the UK. We also examine the factors already in place prior to the pandemic that were a necessary condition for developing a vaccine quickly.

The paper focuses on the Oxford/AstraZeneca vaccine as a case study to help surface lessons from the wider procurement programme. Although it was one of many vaccines procured by the Government, development of the Oxford/AstraZeneca vaccine took place mostly in the UK and so provides a window into how the Government influenced each stage of the process.

We find that government played a key role in expediting every stage of the Ox/AZ vaccine development process. Based on our analysis we identify six lessons for future industrial policy:

  1. Choose a small number of clear, measurable missions and make them a priority at the highest levels of government.
  2. Map out an end-to-end path to success. 
  3. Harness the public, private and voluntary sectors in co-creating and co-delivering industrial policy.
  4. Use strategic procurement and financial insurance to drive progress against industrial policy objectives.
  5. Provide long-term investment at scale as part of sector strategies to maximize the UK’s industrial, commercial and technological strengths.
  6. Build resilience as part of industrial policy.

 

Download

Subscribe to receive updates

Scroll to top